NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2021-2028

Lifesciences | Medical Devices & Consumables

NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2021-2028

Market by Procedure, Type of Infection, Industry Vertical, Product, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The finding of an in-depth research conducted by Triton shows that the North America surgical site infection control market will progress with a CAGR of 5.53% in terms of revenue over the forecast phase of 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market are:

•           The United States

•           Canada

According to a report published by the Centers for Disease Control and Prevention (CDC) in 2019, in 2014, around 14.2 million surgical procedures were performed in inpatient settings in hospitals in the United States in the year 2014. As per the CDC’s survey to determine the prevalence of healthcare-associated infections (HAI), in 2015, close to 110,800 surgical site infection (SSI) cases were detected in patients. The approximate number of surgical site infection cases in the United States per year is around 160,000 to 300,000. These infections incur huge costs, ranging from $3.5 billion to $10 billion.

With the number of surgical procedures being conducted rising continuously, the incidence of SSIs is also rising. This makes it extremely crucial to prevent these infections from occurring. The National Healthcare Safety Network (NHSN), is a web-based surveillance system used by the CDC to track the cases of surgical site infections. With the help of this network, hospitals, dialysis centers, and other healthcare facilities can collect and report data about the infections. These instances show that the US is taking efforts to decrease and prevent the SSI cases in the country. Such measures are proving beneficial for the growth of the United States’ surgical site infection control market.

Founded in 1949 as a paper broking and converting company, Pacon Manufacturing Corporation developed the first sterilizable paper to be used in wound care dressings. With the development of this product, the company delved into the medical marketplace, engaging in flexographic printing. Pacon has developed products to convert and package sterile towels, dressings, drapes, towels, and procedural kits for medical procedures. It is headquartered in New Jersey, the United States. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTE PRODUCTS

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. COMPETITIVE RIVALRY

2.3. IMPACT OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1. ENACTMENT OF THE BEST INFECTION PREVENTION AND CONTROL PRACTICES

2.7.2. GROWING AGING POPULATION

2.8. MARKET RESTRAINTS

2.8.1. SURGING USE OF OUTPATIENT PROCEDURES

2.8.2. INCREASED USAGES OF MEDICAL DISPOSABLE ITEMS

2.9. MARKET OPPORTUNITIES

2.9.1. RISING INCIDENCE OF SURGICAL PROCEDURES

2.9.2. SIGNIFICANT RISE IN THE OCCURRENCE OF COMPLICATIONS FROM HEALTHCARE-ASSOCIATED INFECTIONS

3.    SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY PROCEDURE

3.1. LAPAROSCOPY

3.2. ORTHOPEDIC SURGERY

3.3. CARDIOVASCULAR

3.4. OBSTETRICS AND GYNECOLOGY

3.5. WOUND CLOSURE

3.6. PLASTIC & RECONSTRUCTIVE SURGERY

3.7. THORACIC SURGERY

3.8. MICROVASCULAR

3.9. UROLOGY

3.10. NEUROSURGERY

3.11. OTHER PROCEDURES

4.    SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY TYPE OF INFECTION

4.1. SUPERFICIAL INCISIONAL SSI

4.2. DEEP INCISIONAL SSI

4.3. ORGAN OR SPACE SSI

5.    SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY INDUSTRY VERTICAL

5.1. HOSPITALS

5.2. AMBULATORY SURGICAL CENTERS

6.    SURGICAL SITE INFECTION CONTROL MARKET OUTLOOK – BY PRODUCT

6.1. DISINFECTANTS

6.2. MANUAL REPROCESSORS SOLUTION

6.3. SURGICAL DRAPES

6.4. SURGICAL GLOVES

6.5. SKIN PREPARATION SOLUTION

6.6. SURGICAL IRRIGATION

6.7. SURGICAL SCRUBS

6.8. HAIR CLIPPERS

6.9. MEDICAL NONWOVENS

6.10. OTHER PRODUCTS

7.    SURGICAL SITE INFECTION CONTROL MARKET - NORTH AMERICA

7.1. COUNTRY ANALYSIS

7.1.1. THE UNITED STATES

7.1.2. CANADA

8.    COMPANY PROFILES

8.1. SOTERA HEALTH LLC

8.2. PACON MANUFACTURING CORPORATION

8.3. STERIS CORPORATION

8.4. AMERICAN POLYFILM

8.5. BIOMERIEUX SA

8.6. STRYKER CORPORATION

8.7. BELIMED AG

8.8. GAMA HEALTHCARE

8.9. BECTON DICKINSON AND COMPANY (BD)

8.10. 3M COMPANY

8.11. GETINGE AB

8.12. JOHNSON & JOHNSON

8.13. ANSELL LTD

8.14. KIMBERLY-CLARK

8.15. LAC-MAC

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1. OBJECTIVES OF STUDY

9.1.2. SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1. PRIMARY DATA SOURCES

9.2.2. SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1. EVALUATION OF PROPOSED MARKET

9.3.2. IDENTIFICATION OF DATA SOURCES

9.3.3. ASSESSMENT OF MARKET DETERMINANTS

9.3.4. DATA COLLECTION

9.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1        NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

TABLE 2        VENDOR SCORECARD

TABLE 3        NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2021-2028 (IN $ MILLION)

TABLE 4        NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2021-2028 (IN $ MILLION)

TABLE 5        NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2021-2028 (IN $ MILLION)

TABLE 6        NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 7        NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 2      TYPES OF HEALTHCARE-ASSOCIATED INFECTIONS

FIGURE 3      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)

FIGURE 4      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 5      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)

FIGURE 6      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 7      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)

FIGURE 8      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 9      NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)

FIGURE 10   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)

FIGURE 11   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)

FIGURE 12   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)

FIGURE 13   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)

FIGURE 14   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)

FIGURE 15   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)

FIGURE 16   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)

FIGURE 17   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)

FIGURE 19   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)

FIGURE 20   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)

FIGURE 21   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)

FIGURE 22   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)

FIGURE 23   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)

FIGURE 24   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)

FIGURE 25   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)

FIGURE 26   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)

FIGURE 27   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)

FIGURE 28   NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

FIGURE 29   THE UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION)

FIGURE 30   CANADA SURGICAL SITE INFECTION CONTROL MARKET 2021-2028 (IN $ MILLION) 

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying